Thema: US3632252025
GALT, US3632252025
bitcoin-6537381_1920.jpg - Foto: THN
Galectin Therapeutics stock: AASLD presentations spotlight belapectin
Galectin Therapeutics stock traded at 3.14 euros in late trading on Wednesday. The company is due to present belapectin analyses at AASLD from November 5 to 9.
ad-hoc-news.de, vor 34 Minuten
GALT, US3632252025
MarketBeat cites USD 11.00 target for Galectin Therapeutics ...
Galectin Therapeutics lost USD 9.18 million in the second quarter of 2026. Galectin Therapeutics stock costs EUR 3.09 on October 20, 2026.
ad-hoc-news.de, 20.10.26 19:25 Uhr
GALT, US3632252025
Galectin Therapeutics stock has November 13 earnings USD ...
June 30 earnings per share were USD -0.14. Galectin Therapeutics stock was USD 3.62 on October 16, 2026, down 2.43 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 19:28 Uhr
GALT, US3632252025
Galectin Therapeutics seeks 250 million shares: what it ...
A July conversion eliminated USD 91.0 million of principal. For Galectin Therapeutics stock, the proposal would authorize 250 million shares.
ad-hoc-news.de, 06.10.26 04:53 Uhr
Legal, Scrutiny
Legal Scrutiny Clouds Galectin Therapeutics’ Clinical ...
Galectin Therapeutics US3632252025
boerse-global.de, 07.02.26 19:25 Uhr
Galectin, Therapeutics
Galectin Therapeutics Shares Extend Losses Into Third Session ...
